Rick Simpson Oil (RSO) in San Juan County, Colorado: The Complete Guide by OilWell Cannabis

If you’re living in San Juan County, perched among the San Juan Mountains at 9,000+ feet, you already know what it means to be resilient. Whether you’re navigating the switchbacks of the Alpine Loop, working the remaining mining operations, or helping a neighbor through another long winter, you understand that real solutions come from real experience—not from corporate boardrooms or marketing hype.

We’ve built OilWell Cannabis for people exactly like you. We’re a Houston-based company, but our roots are in the kind of hard places that mirror the challenges of mountain living: limited access, self-reliance, and the understanding that when the system fails you, you find another way. Our founder, Colin Valencia, grew up in McAllen, Texas, a border town where hardship was the daily reality, and he learned early that cannabis could be a lifeline when pharmaceuticals and institutions fell short.

This guide is for every Silverton resident who’s heard about Rick Simpson Oil but doesn’t know what’s real and what’s myth. For every backcountry skier dealing with chronic pain from old injuries. For every retiree in the San Juan Mountains struggling with sleep and arthritis. For every veteran in our remote Colorado communities dealing with PTSD. We’re going to give you everything—no bullshit, no snake oil, just the complete truth about RSO, our formulas, and how they might fit into your life here in San Juan County.

Who Was Rick Simpson and Why Should San Juan County Residents Care?

Rick Simpson was a power engineer from Nova Scotia—not a doctor, not a scientist, just a blue-collar tradesman like many folks in our Colorado mining towns. In 1997, he fell from scaffolding at a hospital in Moncton and suffered a serious head injury. The aftermath left him with persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t fix. Sound familiar? We hear this story a lot from San Juan County residents who’ve taken falls on the trails, had accidents on the job, or dealt with chronic symptoms long after the initial injury should have healed.

When Simpson asked his doctor about cannabis, the request was refused . So he went his own way. He learned about a 1974 NIH-funded study at the Medical College of Virginia where THC was reported to slow tumor growth in mice—though that study was never replicated in human trials . Then in 2003, he claimed that applying concentrated cannabis oil to three basal cell carcinoma lesions on his arm made them disappear in four days. No biopsy, no independent medical verification, no clinical documentation—just his personal testimony .

Important context: We’re telling you Simpson’s story exactly as he told it because it’s historically significant—the catalyst for a global movement. But we need to be crystal clear: this is personal testimony, not medical evidence. In San Juan County, where we value honesty and straight talk, we won’t insult your intelligence by pretending anecdotal stories equal clinical proof.

The Traditional RSO Protocol: 60 Grams Over 90 Days

Simpson developed a specific regimen that became legendary in cannabis circles. Understanding it matters because if you’ve been researching RSO online, this is what you’ve found. But as you’ll see, it’s fundamentally different from what we offer at OilWell.

The Goal

Consume 60 grams of concentrated cannabis oil over roughly 90 days. Simpson considered this the minimum for serious conditions like cancer.

The Titration Schedule

• Week 1: Start with a dose the size of half a grain of rice—about 10-15 mg—three times daily (morning, afternoon, before bed). Total: 30-45 mg per day.
• Weeks 2-5: Double the dose every four days. By week five, reach approximately 1 gram (1,000 mg) per day, divided into three doses.
• Weeks 5-12: Maintain 1 gram daily until all 60 grams are consumed.

Administration Methods

Simpson recommended:

• Oral/sublingual as primary method for systemic absorption
• Topical application for skin lesions, covered with bandages
• Not as primary—inhalation for immediate symptom relief only

Tolerance and Psychoactivity

Simpson claimed patients develop tolerance to THC’s high within 3-4 weeks. He advised nighttime dosing initially and warned against driving during titration .

Critical Safety Context for San Juan County

This protocol has never been validated in controlled trials. It assumes crude, unstandardized material with unknown potency. At peak dosing, patients consumed roughly 600-900 mg of delta-9 THC daily—a dose far exceeding anything studied clinically. The risks at these levels include severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder [1][13][14][15].

For our neighbors in Silverton and throughout San Juan County dealing with altitude sickness, heart conditions, or isolation from immediate medical care, these risks are especially serious. If you’re considering any high-dose cannabis protocol, you need to coordinate with healthcare providers—whether that’s the San Juan Regional Medical Center in Durango or your primary care physician.

What Traditional RSO Actually Was

Understanding the original product helps you evaluate what’s being sold as “RSO” today, whether in Durango dispensaries or online.

Source Material

Simpson used single-strain, high-THC indica cannabis. No standardization—every batch varied based on genetics and growing conditions.

Extraction Solvent

He used naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other carcinogens. Residual solvent contamination is a major safety concern .

Extraction Process

1. Soak cannabis in solvent
2. Agitate and filter
3. Evaporate solvent in a rice cooker
4. Transfer tar-like oil to syringes

The process destroys terpenes and converts all THCa to THC through heat decarboxylation.

Appearance and Profile

• Looks: Nearly black, thick, tar-like substance
• Cannabinoids: 60-90% delta-9 THC, minor cannabinoids at uncontrolled ratios
• Terpene content: Minimal to none due to heat destruction
• Testing: None. No Certificates of Analysis, no contaminant screening

Residual solvent risk: This is one of the most significant safety concerns with traditional RSO. Without lab testing—impossible in Simpson’s pre-legalization era—there’s no way to verify solvent removal.

Traditional RSO vs. OilWell’s Modern Formulation: What San Juan County Needs to Know

The difference matters because San Juan County residents deserve products that match the sophistication of modern Colorado cannabis science, not the crude methods of 2003.

Dimension	Traditional RSO	OilWell Formulated RSO
Source Material	Single high-THC indica strain	Multi-cannabinoid blend from multiple hemp sources
Extraction	Naphtha or isopropyl alcohol	No solvents—blend of pure cannabinoid distillates
Cannabinoid Profile	THC-dominant, uncontrolled (60-90% THC)	Seven defined cannabinoids at specific ratios: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
Terpene Content	Destroyed by high heat	Live terpenes at 5% with defined seven-terpene profile
Standardization	None—every batch different	Lab-tested with precise mg/mL targets (553 mg/mL)
Lab Testing	Not performed	Full panel: potency, terpenes, pesticides, heavy metals, residual solvents, microbial contaminants
Delta-9 THC Exposure	600-900 mg/day at peak dosing	90 mg total in entire 30 mL bottle
Product Formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa Preservation	No—fully decarboxylated	Yes—1,500 mg THCa as separate ingredient
Evidence Approach	Anecdotal, personal testimony	Research-backed, evidence-weighted from 29 peer-reviewed sources

Why We Diverge from Traditional RSO

Our formulas are intentionally different, for five evidence-motivated reasons:

1. Multi-cannabinoid approach—The entourage effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited [20][29]. For San Juan County residents dealing with complex chronic pain or multiple symptoms, this matters.

2. Terpene preservation—Traditional RSO had no terpenes due to heat destruction. Our formulas include live terpenes at 5% because terpene bioactivity is plausible and supported at the preclinical level [20][21][23][24][25][26][27][28][29]. If you’ve ever enjoyed the piney scent of our local forests or the citrus brightness of high-altitude sunshine, you’ve experienced terpenes.

3. THCa as separate ingredient—We preserve THCa at 1,500 mg because the literature suggests potentially relevant non-psychoactive anti-inflammatory and neuroprotective activity that’s lost when THCa converts to THC [12]. This gives you the choice.

4. Reduced delta-9 dominance—Traditional RSO was 60-90% delta-9. Our formula distributes cannabinoids across seven compounds, reflecting modern research rather than single-compound dominance.

5. Product format innovation—We offer both sublingual oil and vape cartridges, acknowledging that different delivery routes have different pharmacokinetic profiles [14]. Whether you’re dealing with acute pain after a day on Black Bear Pass or need sustained relief through the night at 9,300 feet, you need options.

The Story Behind OilWell Cannabis: From a Paralyzed Dog to San Juan County

OilWell Cannabis wasn’t born in a corporate boardroom. It was born in a moment of desperation, love, and refusal to give up.

Bentley: The Dog Who Started Everything

Bentley was Colin Valencia’s companion through the darkest times. When Bentley fell seriously ill, paralyzed in his hind legs, veterinarians delivered the verdict every pet owner fears: euthanasia was the only humane option. The pain medications would destroy his internal organs. The choice was a painful, prolonged decline or immediate mercy killing.

But Colin had already faced too much loss growing up in the violence of the McAllen-Reynosa border region. He wasn’t ready to let Bentley go.

In a desperate search for alternatives, a rescue worker named Jessica asked him a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience, but it was all recreational. He’d never explored the therapeutic applications. That question exposed a blind spot that became a mission.

Colin learned to create CBD golden paste—a specialized cannabinoid formula for pets. It wasn’t a cure, but it was a lifeline. And that lifeline delivered something veterinary medicine said was impossible: Bentley got up. He walked over and brought Colin his ball to play.

From paralyzed and facing euthanasia to fetching his ball. Dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, dying naturally at age twenty. During those ten years, Colin developed specialized formulas for every age-related condition Bentley faced:

• Neurodegeneration → led to understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → led to CBC’s role in neurogenesis
• Glaucoma → led to THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis → led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working simultaneously

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. This is why our RSO contains seven cannabinoids instead of one or two. It wasn’t a marketing decision—it was born from necessity and love.

Colin’s Personal Journey: PTSD, Benzo Addiction, and Recovery

Colin knows pharmaceutical dependence personally. He struggled with severe PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a feat that’s notoriously difficult and dangerous—using the cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD. This is not theoretical knowledge. He lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Over time, these therapeutic benefits became the core of his work. He’s developed formulas that doctors use for Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. The focus has always been on making cannabis accessible and effective for everyone—including vegans, diabetics, and those with specific health needs.

Seven ABC13 Features: Mainstream Recognition You Can Trust

Between September 2019 and April 2023, ABC13 Houston featured Colin and OilWell in seven news segments. Five different reporters sought him out across four years. No other Houston cannabis operator achieved that frequency or breadth.

When ABC13 needed to explain Delta-8 THC to Houston, they called Colin. When the state banned Delta-8 overnight, they went to his dispensary for the story. When President Biden announced marijuana pardons, they interviewed Colin—who revealed his own cannabis conviction history. When they needed an industry expert for a 4/20 special, it was Colin’s hemp field they filmed.

This matters for San Juan County because: San Juan County has one local newspaper (the Silverton Standard & the Miner) and limited media coverage of cannabis issues. When you’re evaluating a company from out of state, mainstream media validation from a major ABC affiliate is a credibility signal you can verify.

Here are the key quotes that define our philosophy, all preserved from actual broadcasts:

• “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” — September 2019

• “People think that everyone just wants to get high… But that’s a different version of therapy, and people are looking for things to help them with real pain. Pain comes in a lot of different forms.” — March 2021

• “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”* — May 2021 (Delta-8 feature)

• “I would love to see people not get hurt for this anymore.” — October 2022, revealing his own cannabis conviction

• “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.” — April 2023

These features—all independently produced, editorially controlled news segments—establish the credibility that no amount of marketing could replicate.

Current Operations: A Real Company, Not a Ghost Brand

OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). Since 2019, we’ve generated approximately $1 million in annual revenue, maintain a near-5.0 Google rating, and hold a Texas DSHS license.

All artwork, formulations, and packaging are created in-house in Houston using only our own recipes and ideas. We bring Houston grit, McAllen roots, and a builder’s mindset to everything we do, but the posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone.

Business Hours:

• Monday-Thursday: 10:00 AM – 7:00 PM
• Friday-Saturday: 10:00 AM – 10:00 PM
• Sunday: 10:00 AM – 4:00 PM

Contact:

• Phone: (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/
• Instagram: @oilwellcbd

The OilWell RSO Philosophy: Four Principles for San Juan County

Our approach isn’t traditional RSO. It’s a formulated, multi-cannabinoid product informed by the tradition but deliberately evolved to solve the problems that limited Rick Simpson’s original vision.

1. Accessibility Over Gatekeeping

In San Juan County, your nearest dispensary might be 50+ miles away in Durango or Montrose. That’s a three-hour round trip on mountain roads, especially challenging during winter months.

Our model: No medical card required. Age 21+ only. We ship nationwide across the United States and internationally to customers who verify local legality. San Juan County residents can order from home and have our products delivered directly—no mountain drive required.

Simpson believed medicine should be accessible to everyone. We’ve built a product and distribution model that makes that accessible legally, even in the most remote corners of Colorado.

2. Patient-Controlled Potency

Traditional RSO was always fully psychoactive. Our sublingual formula contains 1,500 mg of THCa in its acidic, non-psychoactive form. You decide whether to use it raw for daytime anti-inflammatory benefits (zero impairment) or decarboxylate it into delta-9 THC for full psychoactive potency.

This matters in San Juan County where you might need to:

• Stay sharp for a morning of backcountry skiing (raw THCa)
• Manage evening pain after a day on the trails (decarboxylated)
• Get instant relief from acute symptoms (vape format)

3. Open-Source Formulas

We publish our complete formulas publicly—every cannabinoid, every milligram, every percentage. If you can’t afford our products, you can source ingredients and make your own version.

This resonates with the self-reliant culture of San Juan County. If you’re the kind of person who changes your own oil, fixes your own fence, or grows your own vegetables, you can make your own clinical-grade RSO using our exact recipe.

Simpson gave his oil away for free and taught people how to make it. We adapted that ethos for the modern cannabinoid marketplace: sell a professionally manufactured, lab-tested product AND publish the recipe.

4. Evidence-Informed, Not Evidence-Overstating

The GENERAL KNOWLEDGE section of this document (which we’ll detail below) represents our commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature or clinical trial data. We have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

In San Juan County, where people are practical and skeptical of hype, this matters. You deserve to know exactly what the research shows—and what it doesn’t.

Farm Bill Compliance and the THCa Legal Framework for Colorado

Even though Colorado has legal recreational cannabis, our products are hemp-derived and Farm Bill compliant. Here’s why this matters for San Juan County:

The 2018 Farm Bill legalized hemp products containing less than 0.3% delta-9 THC by dry weight at the federal level. Our RSO Sublingual Oil contains only 90 mg of delta-9 THC in the entire 30 mL bottle—3 mg per mL—well under the threshold.

THCa (tetrahydrocannabinolic acid) is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC, making it Farm Bill compliant at the point of sale.

The Practical Significance for San Juan County

You can legally purchase our products online from anywhere, including remote San Juan County. We ship with full documentation, Certificates of Analysis, and receipts. This means:

• No 3-hour drive to Durango if you’re housebound due to pain or weather
• Consistent product every time, unlike variable dispensary offerings
• Lower cost than many Colorado dispensary RSO products (we’ll explain why later)

THCa Decarboxylation: Your Choice, Your Control

Here’s where the science gets fascinating and uniquely relevant to Colorado’s cannabis-savvy population:

Option 1 — Raw (Non-Psychoactive): Use the oil as-is. All 1,500 mg stays as THCa, providing potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. Perfect for daytime use when you need to stay sharp for mountain driving, operating equipment, or working outdoors.

Option 2 — Fully Activated (Home Decarboxylation): Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 mg THCa into approximately 1,315 mg delta-9 THC. Combined with the existing 90 mg delta-9 THC, you get approximately 1,405 mg total delta-9 THC—giving you psychoactive potency comparable to traditional high-THC RSO, entirely at your discretion after purchase.

Option 3 — Vape (Auto-Decarboxylation): Our vape cartridge operates at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Fastest onset available.

The chemistry: THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation.

This design puts the potency decision entirely in your hands—aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing it through actual product chemistry rather than forcing you into a one-size-fits-all approach.

Important Legal Notice for San Juan County and Colorado

THCa converts to delta-9 THC when heated. By purchasing our products, you accept responsibility for understanding and complying with Colorado law. While Colorado allows recreational cannabis, our products are hemp-derived and Farm Bill compliant. San Juan County residents who choose to decarboxylate at home are consuming a product that becomes comparable to state-legal cannabis. We ship with full documentation, but you assume all responsibility for use and decarboxylation decisions.

Open-Source Formulas: Full Transparency for Self-Reliant Coloradans

We publish our complete formulas because we trust San Juan County residents to make informed decisions. If you can’t afford our products, you can source the ingredients and make your own. This is the recipe that saved Bentley’s life and that Colin used to quit Xanax.

CBD Golden Paste Recipe for Pets (The Original Open-Source Formula)

This is the formula Colin published years before we released our RSO formulas—demonstrating that our open-source ethos is foundational, not marketing.

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (critical for absorption)
• CBD oil (dosage depends on pet size; consult a veterinarian)

Instructions:

1. Mix turmeric and water in a saucepan over low heat, stirring continuously until thick paste forms (7-10 minutes)
2. Add coconut oil and black pepper, stir until thoroughly mixed
3. Allow to cool, store in refrigerator up to two weeks
4. Mix CBD oil into paste before serving

Serving: Mix small amount with pet’s food once or twice daily. Always consult a veterinarian first.

For San Juan County pet owners dealing with aging animals in remote areas where vet access is limited, this recipe might be a lifeline—just as it was for Bentley.

Solvent-Free Production: What San Juan County Should Demand

Traditional RSO used toxic solvents. We take a completely different approach:

• No solvents in our production process
• Organic MCT oil as the carrier base—food-grade, facilitates sublingual absorption, neutral taste
• Third-party lab testing covering: cannabinoid potency, terpene profile, pesticides, heavy metals, residual solvents, microbial contaminants
• Certificates of Analysis (COAs) available on request and through our website

This matters for San Juan County because at high altitude, your body is already working harder. You shouldn’t have to worry about solvent residues, pesticide contamination, or inaccurate labeling when you’re trying to manage pain or sleep issues.

The OilWell Product Portfolio Beyond RSO

While this guide focuses on RSO, we want San Juan County residents to know the full range:

Asshole Peach — Our most popular product. Carefully formulated for euphoric, long-lasting sensation. Particularly favored by veterans for pain and PTSD relief without overwhelming intensity.

Peace Gummies — Born from Colin’s own benzo withdrawal experience. The formula that helped him quit Xanax cold turkey, also available in vape form for quick relief. Colin personally uses this for insomnia and severe PTSD.

Custom Creations — We design products for specific needs. Whether you need vegan formulations, diabetic-friendly options, or specific cannabinoid ratios for unique health circumstances, we can create it. For San Juan County residents with specialized dietary needs or complex medical situations, this is a resource worth knowing about.

Two Product Formats: Choose What Works for Your San Juan County Lifestyle

RSO Sublingual Oil — $129.99

Complete Formula:

Cannabinoid	Amount
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16,590 mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle
• Active per mL: 553 mg
• Carrier: Organic MCT oil
• Dosing: Graduated dropper with 0.1 mL increments
• Onset: 15-45 minutes (sublingual)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses per bottle: 40-60 depending on serving size

For San Juan County residents dealing with chronic conditions requiring sustained relief—like arthritis from years of skiing or mining work, or persistent pain from old injuries—this format provides long-lasting effects.

RSO Vape Cartridge — $49.99

Formula:

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• Compatibility: 510-thread universal battery
• Onset: 1-2 minutes (fastest delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (variable)
• Auto-decarboxylation: THCa converts instantly at vaping temperature (400-450°F)

Perfect for breakthrough pain during a long day on the trails, acute nausea from altitude sickness, or panic attacks that need immediate interruption.

When to Use Each Format in San Juan County

Use Case	Recommended Format	Why It Fits San Juan County Life
Fast relief (acute pain, nausea, panic)	Vape	You’re on the mountain, far from help—1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration gets you through the night at altitude
Maximum bioavailability	Sublingual	More efficient absorption for severe conditions
Portability/discretion	Vape	Compact for backpacking or discreet use
Precise dosing control	Sublingual	Graduated dropper for careful titration
Daytime non-psychoactive use	Sublingual (raw)	THCa stays inactive—zero impairment for driving or work
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Activated for full potency when you don’t need to be sharp

Condition-Specific Usage Context for San Juan County Residents

Important Disclaimer: These contexts are informed by the cannabinoid research detailed below, but they are NOT medical prescriptions, NOT FDA-approved treatment protocols, and NOT a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider—whether that’s a physician at San Juan Regional Medical Center in Durango, a specialist in Montrose, or your local provider in Silverton—before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

For San Juan County residents traveling to Durango or Grand Junction for cancer treatment:

• Pre-chemo: 0.5-1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Evidence context: Delta-8 THC antiemetic evidence [9], delta-9 THC nausea/vomiting evidence [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Arthritis, Neuropathy, Old Injuries)

This speaks directly to many San Juan County residents:

• Daytime: 0.3-0.5 mL raw sublingual—anti-inflammatory without impairment
• Nighttime: 0.5-1.0 mL decarboxylated sublingual—pain relief plus CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support at High Altitude

San Juan County’s elevation can disrupt sleep architecture:

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: Delivers 50 mg CBN—the dosage level investigated in 2024 sleep literature [16][17]
• At 1.0 mL: Delivers 25 mg CBN—above the 20 mg threshold associated with reduced sleep disturbance [16]

Anxiety and Stress

For the isolation and challenges of mountain living:

• Daytime functional relief: 0.3 mL raw sublingual—CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0 mL sublingual—full profile including CBN

Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20]

General Titration Principle

Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Delivery to San Juan County: Getting Our Products to You

San Juan County is remote. We know that. Getting to Durango takes over an hour. Montrose is even farther. Winter storms can shut down passes for days. That’s why our delivery system matters.

Nationwide Shipping to San Juan County

• All 50 states where Farm Bill-compliant products are legal—including Colorado
• USPS Priority Mail: 2-3 business days to Silverton or any San Juan County address
• FedEx/UPS Ground: 3-5 business days
• Discreet packaging with no cannabis branding visible—important in small communities
• Tracking provided for all orders
• Temperature-stable packaging for summer shipments (critical at high altitude where sun is intense)
• Signature-required option available

The typical delivery time to San Juan County is 2-4 business days from our Houston facility. For a rural area where the nearest specialty store might be a 3-hour drive, that’s accessible.

International Shipping

We ship internationally to jurisdictions where hemp-derived products with <0.3% delta-9 THC are permitted. For San Juan County residents with family or property outside the U.S., this is a unique resource.

All international packages include full documentation, COAs, and receipts for customs. The customer is responsible for verifying legality in their jurisdiction and accepts all customs/legal risk.

How Our Formulas Connect to the Evidence Base

Every cannabinoid in our formula has its own evidence profile in the peer-reviewed literature. We’re not asking you to trust marketing claims—we’re showing you the research.

The Evidence Hierarchy We Use

1. Human clinical evidence (strongest)
2. Systematic reviews and meta-analyses
3. NIH and institutional summaries
4. Preclinical/mechanistic literature (when human data is sparse)

This weighting matters because the evidence base is not evenly distributed. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews, animal work, and pharmacology studies [1]-[29].

NIH and Institutional Baseline

The National Center for Complementary and Integrative Health (NCCIH) states that the strongest established cannabinoid evidence is for:

• Certain rare epilepsies (CBD)
• Chemotherapy-related nausea and vomiting (THC)
• Appetite/weight loss in HIV/AIDS (THC)

NCCIH notes only modest evidence for chronic pain and multiple sclerosis symptoms, with many other claimed uses still in early-stage research [1].

Safety concerns highlighted by NIH include impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination, labeling inaccuracy, and THC-vape lung injury concerns [1].

CBD (Cannabidiol)

Evidence profile: Strongest human evidence in our formula set, especially as purified product [1]-[6].

Best supported: Seizure disorders—most credible major-example indication acknowledged by institutional literature [1][2].

Anxiety: 2024 systematic review of 316 participants across eight studies reported significant anxiolytic signal, but authors stress clinical sample remains limited [3].

Pain: 2024 systematic review concluded literature is promising but heterogeneous, with trial quality limiting confidence [4].

Sleep: 2023 insomnia review found literature methodologically weak, with few objective sleep assessments [5].

Safety: 2023 systematic review found signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy settings [6]. NCCIH also flags diarrhea, sleepiness, appetite changes, mood effects, and drug-drug interactions [1].

Bottom line: CBD is most evidence-developed nonintoxicating cannabinoid, but strong evidence is concentrated in specific indications rather than broad wellness claims [1]-[6].

CBG (Cannabigerol)

Evidence profile: Mostly review-level and preclinical; human evidence sparse [7][8].

Pharmacology: CBG is biosynthetic precursor to major cannabinoids with distinct pharmacology including interactions with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling [7].

Potential areas: Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are primarily pharmacology-led hypotheses [7][8].

Caution: 2021 pharmacology review notes CBG is already sold commercially while evidence base remains thin—claims frequently outrun science [7].

Bottom line: CBG is promising minor cannabinoid with limited clinical validation [7][8].

Delta-8 THC

Evidence profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 [9]-[11].

Comparative pharmacology: 2022 review concluded delta-8 and delta-9 have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 is partial CB1 agonist with cannabimimetic activity, but appears less potent than delta-9 [9].

Public health: 2023 scoping review found evidence base dominated by animal studies, product chemistry, use reports, and public-health concerns rather than strong human trials. Noted reports of adverse consequences and emphasized regulatory/product-quality concerns [10].

Manufacturing: 2024 chemistry review notes commercial delta-8 interest tied to greater stability and easier synthesis relative to naturally scarce plant levels, which is why product-byproduct and lab-testing questions matter [11].

Bottom line: Delta-8 is psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and manufacturing-quality uncertainty [9]-[11].

THCa (Tetrahydrocannabinolic Acid)

Evidence profile: Important chemically/formulation-wise, but low on direct human therapeutic evidence [12].

What it is: Acidic precursor to THC. Represents large share of THC-related content in raw plant material. Decarboxylates into THC during heating and can change during storage/processing [12].

Psychoactivity: THCa itself does not produce THC’s psychoactive effects, but distinction only holds if molecule stays acidic and isn’t substantially decarboxylated [12].

Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but not equivalent to established human outcomes [12].

Bottom line: THCa is highly relevant precursor whose interpretation depends heavily on route, temperature, processing, storage [12].

Delta-9 THC

Evidence profile: Strongest human evidence of psychoactive cannabinoids, but also clearest adverse-effect burden [1][13]-[15].

Institutionally best supported: NCCIH identifies THC-containing medicines as relevant to chemo-related nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes, while stressing many other uses remain uncertain [1].

Pain evidence: 2022 systematic review found cannabis-based products with high THC or comparable THC:CBD ratios may provide short-term pain benefit, but increased dizziness, sedation, nausea, and treatment discontinuation [13].

Pharmacokinetics: Inhaled THC: effects within seconds-minutes, peak 15-30 minutes, taper over few hours. Oral THC: later onset, later peak, longer duration—matters for both benefit and overconsumption risk [14].

Mental health risk: 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, with concerning signals for anxiety/depression [15].

Bottom line: Delta-9 THC has legitimate therapeutic relevance but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15].

CBN (Cannabinol)

Evidence profile: Weak human evidence; marketing ahead of data [12][16][17].

What it’s marketed for: Sleep and sedation. Reputation widespread, but clinical support far thinner than market suggests [16][17].

Best direct review: 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16].

Broader sleep literature: 2024 updated review concluded overall cannabinoid sleep research doesn’t match real-world use scale, need for better-designed trials remains substantial [17].

Bottom line: CBN is clearest example where cultural reputation is stronger than current clinical evidence base [16][17].

CBC (Cannabichromene)

Evidence profile: Emerging, intriguing, overwhelmingly preclinical/review-based [18][19].

Pharmacology: 2024 focused review argues CBC has distinct pharmacodynamics, pharmacokinetics, receptor behavior relative to better-known cannabinoids, highlights antinociceptive, antibacterial, anti-seizure as interesting research targets [18].

Older literature: Review literature reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, possible neurobiological/antiproliferative relevance—not yet strong patient-facing evidence [19].

Safety caveat: 2024 CBC review notes over-the-counter CBC products already sold despite little evidence establishing clinical efficacy or safety [18].

Bottom line: CBC is scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19].

Terpenes: The Aromatics of the San Juan Mountains

If you’ve hiked through the pine forests above Silverton or smelled wildflowers in Yankee Boy Basin, you’ve experienced terpenes. These aromatic compounds are what give cannabis its distinctive scents and flavors, and they may contribute to therapeutic effects.

Evidence Considerations for San Juan County

Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

However, the aromatherapy tradition is strong in mountain communities, and many San Juan County residents intuitively understand that plant aromas affect mood and wellbeing. We include live terpenes at 5% because the science is plausible and evolving.

Our Seven-Terpene Profile

Limonene (citrus-bright)

• Evidence: Review and preclinical, multifunctional antioxidant/anti-inflammatory [21]
• Safety note: Oxidation products are contact allergens [22]

Myrcene

• Evidence: Mostly preclinical, anxiolytic/anti-inflammatory/analgesic properties but human studies lacking [23]

Caryophyllene (β-caryophyllene – pepper/spice)

• Evidence: Selective CB2 receptor agonist—most cannabinoid-system relevant terpene [24]
• Research: Anti-inflammatory, immunomodulatory, neuroprotective, gastroprotective [24]

Pinene (forest-fresh)

• Evidence: Promising preclinical, weak human confirmation
• Brain health: Antioxidant, anti-inflammatory, neuroprotective signals [25]

Linalool (floral, lavender)

• Evidence: Substantial preclinical interest, limited direct clinical confirmation
• Research: Stress, mood, neuropharmacology [25][26]
• Safety: Oxidized hydroperoxides are allergens [22]

Humulene (earthy, woody)

• Evidence: Translationally interesting but early
• Research: Anti-inflammatory, some rodent work suggests cannabimimetic properties [27]

Terpinolene (piney, fruity, sparkling)

• Evidence: Least clinically characterized in this profile
• Research: Dominated by in silico, in vitro, animal studies [28]

Bottom line: Terpenes make our product smell and taste distinctive, and they may contribute to effects, but clinical claims should stay conservative [20][29].

Research Limits and Interpretation: The Honest Truth

1. Evidence is highly uneven. CBD and delta-9 THC can support the most detailed human-facing statements; the rest require more caution [1]-[29].

2. Extract vs. molecule vs. synthetic vs. terpene data aren’t interchangeable. One common error is letting evidence from one category stand in for another.

3. Minor cannabinoids are commercially interesting BECAUSE they’re underexplored, but that also means claims often become inflated.

4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect real-world interpretation [1][10][11][14].

5. For THCa, chemistry is destiny. Storage and heating can change exposure profile by converting acidic cannabinoids to neutral forms like THC [12].

Common Overstatements to Avoid (What Other Companies Get Wrong)

• Overstatement: CBN is clinically proven sleep aid.
  More accurate: Sleep evidence for CBN remains weak, no strong validated-trial base [16][17].

• Overstatement: Myrcene is proven human sedative causing couch-lock.
  More accurate: Plausible preclinical bioactivity, but direct human proof limited [20][23].

• Overstatement: Terpenes have proven entourage effects in patients.
  More accurate: Hypotheses influential and worth studying, but robust clinical proof limited [20][29].

• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa isn’t THC, but heating/processing converts it to THC, changing exposure [12].

• Overstatement: Delta-8 THC is safe because hemp-derived.
  More accurate: Psychoactive, pharmacologically close to delta-9, with manufacturing/testing concerns [9]-[11].

Practical Takeaways for San Juan County

1. CBD and delta-9 THC have strongest human evidence in our formulas
2. Delta-8 THC is not trivial—it’s psychoactive with less robust safety/efficacy data than delta-9
3. THCa meaningfully changes with processing—not same in raw, handled, and heated formats
4. CBG, CBN, CBC are scientifically credible but clinically immature compared to CBD/THC
5. Terpene claims should be careful—plausible but not clinically proven for most outcomes

RSO Sublingual Oil Formula: The Complete Recipe

Cannabinoid	Amount
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16,590 mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL
• Active per mL: 553 mg
• Suggested starting dose: 0.25-0.5 mL
• Price: $129.99

RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• Compatibility: 510-thread
• Price: $49.99

Complete Terpene Profile (Both Products)

• Limonene (citrus-bright)
• Myrcene (earthy, mildly sweet)
• Caryophyllene (β-caryophyllene—pepper/spice)
• Pinene (forest-fresh)
• Linalool (floral, lavender)
• Humulene (earthy, woody)
• Terpinolene (piney, fruity, sparkling)

Complete References

Rick Simpson Section References

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.

RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005. Distributed via phoenixtears.ca and online platforms.

RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca. Multiple dates. Accessed March 2026.

RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444. PMID: 22555283.

RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203. PMID: 16804518.

RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024. Available at: https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq

General Knowledge References

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know

2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.

3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.

4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.

5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.

6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.

7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.

8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.

9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.

10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.

11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.

12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.

13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.

14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.

15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.

16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.

17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.

18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.

19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.

20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.

21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.

22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.

23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.

24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.

25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.

26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.

27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.

28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.

29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

Final Thoughts for San Juan County

We know you’re skeptical. We know you’ve seen every kind of health promise come and go. We know that living in a place as beautiful and challenging as San Juan County teaches you to differentiate between what sounds good and what actually works.

That’s why we don’t promise miracles. We promise transparency: our complete formulas, our complete evidence base, our complete story—including the parts that don’t fit neatly into a marketing narrative.

Rick Simpson’s legacy is important. He opened doors. He made people ask questions about cannabis that needed asking. But his methods were a product of his time—crude, unstandardized, and sometimes unsafe by modern standards.

We’ve taken his core insight—that concentrated cannabinoids can help people in ways pharmaceuticals sometimes can’t—and built something that reflects everything we’ve learned since. Seven cannabinoids, seven terpenes, solvent-free, lab-tested, patient-controlled, and open-source.

Whether you’re dealing with chronic pain from a lifetime of mountain living, helping a pet through their final years, or just curious about what the science actually says, we’re here. No snake oil. No hope-peddling. Just the best possible version of the information and products, so you can decide what’s right for you.

From our home in Houston to your home in Silverton, from the Texas Medical Center to the San Juan Mountains—we’re committed to integrity, education, and the mission that started when a paralyzed dog got up and brought his ball to play.

Order today: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

Questions? Call (832) 416-2816 or email [email protected]

Visit us: 810 Richmond Avenue, Houston, TX 77006 (Montrose neighborhood)

Follow: @oilwellcbd on Instagram

All content © 2024 OilWell Cannabis. These statements have not been evaluated by the FDA. Products not intended to diagnose, treat, cure, or prevent any disease. Must be 21+ to purchase. Buyer assumes all responsibility for compliance with local laws.